The Cooper Companies, Inc. (NASDAQ:COO) Given Consensus Rating of “Hold” by Analysts

Shares of The Cooper Companies, Inc. (NASDAQ:COO) have received an average rating of “Hold” from the seventeen ratings firms that are currently covering the company, MarketBeat Ratings reports. Three research analysts have rated the stock with a sell rating, six have issued a hold rating, seven have assigned a buy rating and one has issued a strong buy rating on the company. The average 1-year price target among brokers that have covered the stock in the last year is $81.6429.

A number of research firms have recently weighed in on COO. Citigroup reaffirmed a “neutral” rating and set a $80.00 price target (up from $76.00) on shares of Cooper Companies in a research note on Thursday, August 13th. UBS Group initiated coverage on Cooper Companies in a report on Tuesday, July 28th. They issued a “neutral” rating and a $75.00 price objective on the stock. KeyCorp reaffirmed a “sector weight” rating on shares of Cooper Companies in a research report on Friday, June 5th. Needham & Company LLC reduced their target price on shares of Cooper Companies from $101.00 to $86.00 and set a “buy” rating for the company in a research note on Friday, June 5th. Finally, Robert W. Baird decreased their target price on shares of Cooper Companies from $98.00 to $85.00 and set an “outperform” rating for the company in a research report on Friday, June 5th.

Institutional Investors Weigh In On Cooper Companies

A number of large investors have recently bought and sold shares of COO. Avalon Trust Co bought a new position in Cooper Companies during the second quarter valued at about $25,000. Root Financial Partners LLC lifted its position in shares of Cooper Companies by 104.5% in the fourth quarter. Root Financial Partners LLC now owns 317 shares of the medical device company’s stock worth $26,000 after buying an additional 162 shares during the last quarter. SJS Investment Consulting Inc. boosted its stake in shares of Cooper Companies by 107.5% during the 1st quarter. SJS Investment Consulting Inc. now owns 361 shares of the medical device company’s stock worth $26,000 after acquiring an additional 187 shares in the last quarter. Elevation Wealth Partners LLC boosted its stake in shares of Cooper Companies by 1,136.4% during the 2nd quarter. Elevation Wealth Partners LLC now owns 408 shares of the medical device company’s stock worth $29,000 after acquiring an additional 375 shares in the last quarter. Finally, Continuum Advisory LLC acquired a new position in shares of Cooper Companies during the 2nd quarter valued at about $30,000. 24.39% of the stock is currently owned by institutional investors.

Cooper Companies Trading Down 1.5%

NASDAQ COO opened at $70.09 on Tuesday. Cooper Companies has a 1-year low of $58.89 and a 1-year high of $89.83. The company has a current ratio of 1.27, a quick ratio of 0.78 and a debt-to-equity ratio of 0.23. The company has a market capitalization of $13.67 billion, a PE ratio of 59.40, a price-to-earnings-growth ratio of 1.86 and a beta of 0.83. The firm’s fifty day simple moving average is $72.66 and its 200-day simple moving average is $70.73.

Cooper Companies (NASDAQ:COO) last released its quarterly earnings data on Thursday, June 4th. The medical device company reported $1.21 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.10 by $0.11. Cooper Companies had a return on equity of 10.88% and a net margin of 5.57%.The firm had revenue of $1.08 billion during the quarter, compared to analysts’ expectations of $1.05 billion. During the same quarter last year, the firm earned $0.96 earnings per share. The business’s revenue for the quarter was up 7.9% on a year-over-year basis. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. As a group, sell-side analysts anticipate that Cooper Companies will post 4.63 earnings per share for the current fiscal year.

Cooper Companies Company Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.